- 優先名称
- 2,3-Dihydroxy-6-(hydroxymethyl)-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl 4-O-hexopyranosylhexopyranoside
- IUPAC
- 2,3-Dihydroxy-6-(hydroxymethyl)-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl 4-O-hexopyranosylhexopyranoside
- 現地名
- バリダマイシンE
- 英語名
- 4-O-[4-O-(α-D-Glucopyranosyl)-β-D-glucopyranosyl]-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-1,5,6-trideoxy-D-chiro-inositol
- 分子式
- C26H45NO18
- 分子量
- 659.63
名称と別名
バリダマイシンE(2R,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(1R,2R,3S,4S,6R)-2,3-ジヒドロキシ-6-(ヒドロキシメチル)-4-{[(1S,4R,5S,6S)-4,5,6-トリヒドロキシ-3-(ヒドロキシメチル)シクロヘキサ-2-エン-1-イル]アミノ}シクロヘキシル]オキシ}-4,5-ジヒドロキシ-2-(ヒドロキシメチル)オキサン-3-イル]オキシ}-6-(ヒドロキシメチル)オキサン-3,4,5-トリオール4-O-[4-O-(α-D-グルコピラノシル)-β-D-グルコピラノシル]-5-(ヒドロキシメチル)-1-[[(1S,4R,5S,6S)-4,5,6-トリヒドロキシ-3-(ヒドロキシメチル)-2-シクロヘキセン-1-イル]アミノ]-1,5,6-トリデオキシ-D-chiro-イノシトールValidamycin E4-O-[4-O-(α-D-Glucopyranosyl)-β-D-glucopyranosyl]-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-1,5,6-trideoxy-D-chiro-inositolD-chiro-Inositol, O-α-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-1,5,6-trideoxy-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-2-[6-[2,3-dihydroxy-6-(hydroxymethyl)-4-[[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol